ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE nod for GSK’s ‘bubble baby syndrome’ gene therapy
pharmatimes
October 24, 2017The National Institute for Health and Care Excellence has published draft guidance recommending GlaxoSmithKline’s gene therapy Strimvelis as an option for treating an ultra-rare immune deficiency condition commonly referred to as bubble baby syndrome.
Pharma Sources Insight January 2025
